Past Events

PatientSafe INDIA is the annual event organized as a part of the industry initiative on tackling Drug Counterfeiting. The initiative is being planned by OPPIwith the support of affiliate associations like IDMA, IPA, IMA and AIOCD and is being facilitated by SynCore Consulting.

The aim of the initiative is to ensure patient safety by addressing the challenge of drug counterfeiting through programs such as trade meets, round tables and conferences.

At the 6th FICCI – HADSA International Nutraceutical Conference (held in Mumbai on 6th May 2015) with the Theme “Make in India – Nutraceutical Opportunities”, SynCore Consulting and FICCI – HADSA came together to understand the requirements of the Indian manufacturing sector to become a recognized global supplier of nutraceuticals.


A Knowledge Report was launched entitled "Make in India - Nutraceuticals Opportunities" published by SynCore Consulting (Knowledge Partner) and FICCI-HADSA

SynCore Consulting now is nominated as one of '25 Most Promising Business Consultant Companies in India' by Consultants Review Magazine. You can read a complete interview of Mr. Javin Bhinde, Executive Director - SynCore Consulting Group in the December 2014 issue of Consultants Review Magazine.

SynCore @ TEDx

Vitality of adapting to changing times and trends | Javin Bhinde | TEDxNMIMS

Javin spoke about the vitality of adapting to changing times and trends. Only 70 of the Fortune 500 companies in the 1995 list feature in the 2014 list. He stressed on the importance of remaining essential and beating competition of all kinds, in all forms, by staying alert and being prepared for all eventualities. And perceiving and being flexible and adaptable to emerging trends.

Please reload


SynCore Consulting Pvt. Ltd 2016 © All RIGHTS RESERVED 

UBM SCM Pharma Summit 2014

Mr. Javin Bhinde (Director - SynCore Consulting Group) was invited by the UBM and CPHI to express his views on the subject of: 'Discussing the importance of reverse logistics process in the Indian pharma industry to reduce the impact of loss of revenue due to expiry of high value drugs' at the CPHI SCM Pharma SUMMIT on 16-17 October 2014 at Westin, Mumbai.